Part D PDE Data and the Opioid Epidemic

Similar documents
Medicare Part D Overutilization Monitoring System

Medicare-Medicaid Data Integration (MMDI) Use Case: Profiling the Provider Role in Opioid Prescribing Among Dual Eligibles

Medicare-Medicaid Data Integration (MMDI) Use Case: Profiling Potential Opioid Misuse among Dual Eligibles

Amy Larrick Chavez-Valdez, Director, Medicare Drug Benefit and C & D Data Group

Medicare Advantage Outreach and Education Bulletin

E-Prescribing, EPCS & PDMP: An Update

Physician Injectable Drug List (PIDL) Department for Medicaid Services, HP, and Magellan Rx Management June 1, 2010

New patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit:

DENOMINATOR: All patients 18 and older prescribed opiates for longer than six weeks duration

HOSPICE INFORMATION FOR MEDICARE PART D PLANS

Medicare Part D Opioid Policies for 2019 Information for Patients

2017 PGIP Fact Sheet Electronic Prescribing of Controlled Substances (EPCS)

Alabama Medicaid Pharmacy Override

Access Points: Frequently Asked Questions 15 June 2016

Your Prescription Card. Your guide for savings.

See Important Reminder at the end of this policy for important regulatory and legal information.

Background. CMS finalized new policies for Medicare drug plans to follow starting on January 1,2019.

Texas Vendor Drug Program Specialty Drug List Process. February 2019

WA PMP Access by Public Payers. PDMP North Regional Meeting St. Louis, MO April 23-24

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

Your Prescription Card. Your guide for savings.

Maryland Medicaid ABA Contract Introduction and Overview

POLICY AND PROCEDURE DOCUMENT NAME: Drug Recall Notification Process

Curbing Prescription Drug Abuse in Medicaid

Welcome and Key Contacts

HEDIS 2018 Medications List Directory User Manual

Medicare Advantage Outreach and Education Bulletin

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

Shining a Light on MEDs Understanding morphine equivalent dose

D. Todd Bess, PharmD 1

January 16, Dear Administrator Verma:

Clinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.18

Greetings to all of you who provide valuable and vital health, human and related services in our communities!

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers

Tools and Resources for Dental Offices. Prepared for the Pennsylvania Dental Association

Request for Proposal. PA ACT 139 Naloxone Purchase

Health TALK. Take charge. Health4Me TM. Prepare to see your provider.

Idaho DUR Board Meeting Minutes

All Medicare Advantage, Prescription Drug Plan, Cost, PACE, and Demonstration Organizations Systems Staff

REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax:

Changes to the Eighth Edition

Dental Dialog. Highlighting news, programs, policies and tips for Aetna participating dentists. Fall aetna.com

New Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program Express Scripts Holding Company. All Rights Reserved.

Analyzing the opioid crisis in America

Immunization Conference

News & Views. Antipsychotics on Maryland Medicaid PDL and Coverage of a 30-day Emergency Supply of Atypical Antipsychotics

Section Processing

Clinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.19

An Overview of ProviderConnect. For Applied Behavior Analysis (ABA) Providers

Vaccine Starter Kit Program FAQs

Nebraska: What s Going On with the PDMP and HIE

USE OF OPIODS AT HIGHER DOSES IN PERSONS WITHOUT CANCER: MORPHINE EQUIVALENT DOSE EDIT

PHARMACY COMPLIANCE RISK AREAS FOR 2014

Your Prescription Card. Your guide for savings.

Technical Assistance Guide No Recommended PDMP Reports to Support Licensing/Regulatory Boards and Law Enforcement Investigations

Managed Health Services (MHS) Candace V. Ervin Market Manager, Indiana Provider Relations October 18, 2017

Managing Opioid Overutilization Challenges

Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort

FirstCare Health Plans (FirstCare) is on track to be ICD-10 ready by the October 1, 2015 deadline.

Guideline on the Regulation of Therapeutic Products in New Zealand

PDE File Medication Utilization; Medication Possession Ratio. Kyoungrae Jung, Ph.D. Assistant Professor Penn State University

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

Fertility Center and Sperm Bank Manual for the Fertile Hope Program for Men

Questions and Answers on 2009 H1N1 Vaccine Financing

Additional Information Specification 0003: Rehabilitation Services Attachment

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

Addiction Recovery Treatment Services (ARTS): Billing Best Practices. December 2017

Dentrix Learning Edition

Get the most from your prescription plan

Cortex Gateway 2.0. Administrator Guide. September Document Version C

In-House Chronic Pain and Opioid Use Reporting Guide

Get the most from your prescription plan

Quick-Start Guide. UnitedHealthcare of Minnesota, North Dakota and South Dakota.

Authorization and appeals kit: Psoriatic arthritis

Spring 2018 Health and Wellness Newsletter

Opioid Policy Steering Committee: Prescribing Intervention--Exploring a Strategy for

Complex just became comfortable.

PATIENT SIGNATURE: DOB: Date:

Managed Care Pushes for Safer Opioid Oversight

Using CURES to combat prescription drug abuse/misuse

Medicare Star Ratings and the Shift to Quality- Based Payment Models. David Nau, RPh, PhD, FAPhA PQS President

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

SANOFI PASTEUR INFLUENZA VACCINE PRESENTATIONS CODING AND BILLING CHECKLIST

Please complete the medical history section below so that we can be sure to respond to any

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process-High Priority

WHAT YOU NEED TO KNOW TO ABOUT AB 474

a guide to Reimbursement of Intermittent Catheters Know your options M2116N 04.08

Kansas Department of Health and Environment (KDHE) Kansas Data-Driven Prevention Initiative Request for Proposal (RFP) Fiscal Year 2019

Overview. Provider Enrollment Requirements Member Eligibility Hearing Services Authorization and Billing Additional Information

Opiate Use among Ohio Medicaid Recipients

Applying Population Health Management to Opiate Prescription Medication Misuse

STATE OF NEW JERSEY OFFICE OF THE STATE COMPTROLLER MEDICAID FRAUD DIVISION

Protecting Children s Safety: How Prescription Drug Monitoring Programs Can Assist An Update Presenter: John L. Eadie Moderator: Cindy Rodgers

SPECIAL REPORT: CPT CODES WHAT THERAPISTS NEED TO KNOW

Public Health Impacts of 2016 West Virginia Legislation

PCC EHR Meaningful Use Measures. Maria Horn July 18, :15 pm. Including CQM Reports

SAMPLE. Dental Claim Form. X Patient/Guardian Signature. X Subscriber Signature. X Signed (Treating Dentist) 54. NPI 55.

Transcription:

Part D PDE Data and the Opioid Epidemic State Data Resource Center Acumen, LLC August 30, 2017 3:30-4:30pm ET

Outline Background Information on Opioid Use Helpful Part D Elements for Analysis How to Perform an Analysis How to Request Part D PDE Data Questions and Conclusion 1

Opioids: USA vs. The World 2

Opioids: US Opiate Prescriptions 3

Opioids: Overdoes Deaths 4

Opioid Use: Medicare Part D 5

Part D PDE: Overview The rows in the Part D Prescription Drug Event (PDE) file correspond to prescription fills (Prescription Drug Events). Data elements include: National Drug Code (NDC); Days supply; Quantity dispensed; and Date of service. PDE includes all Medicare Part D beneficiaries, even those under Managed Care. Must keep this in mind when using Part D data in conjunction with Parts A & B data, which contain only A/B Fee-For-Service (FFS) beneficiaries. 6

Part D PDE: Challenges and Limitations The version of the PDE file available to states does not include financial information, such as Medicare or beneficiary payments for drugs. Saving costs is not a permissible data use justification. The NDC is available on the file, but an NDC crosswalk will be needed to make this field meaningful. First DataBank MedKnowledge very complete file you can pay for, with names, prices, and descriptions corresponding to each NDC. Various Public Use Files (PUFs), such as RxNorm and VA National Drug File Free but can be incomplete or difficult to work with. 7

Part D PDE: Final Action Final action refers to the process of choosing the most up-to-date version of a claim. A PDE claim that was previously submitted may be declined or there may be an update or correction to information on the claim. If final action isn t applied, the data will contain records with duplicate information. Requestors have the option of getting final action historic data or non-final action monthly data. 8

Part D PDE: Final Action (Continued) Final action historic data is easy to work with since final action has already been applied, but not very timely. Non-final action data is very up to date (about a month lag between claim processing and receipt of data), but states must apply the final action process. Not very complicated and many resources exist to help states implement final action. Resources Part D Data Netting On-Demand Tutorial Video Part D Netting Explanation Tip Sheet Integrating Monthly Files into Part D Final Action Tip Sheet Locations SDRC Assistance Website ( Reference Docs SDRC On-Demand Tutorials SDRC Tutorial 11 Part D Data Netting SDRC Public Website ( Medicare Data Available Data Dictionaries and File Layouts ) 9

PDE Variables for Opioid Analysis Variable Names Descriptions Examples HICN Unique Beneficiary Identification Number 000-00-0000 Days Supply Days worth of drugs the prescription covers 3 Quantity Dispensed Dosage units of medication dispensed 27 Date of Service Date when a beneficiary picked up the prescription from pharmacy 24 MAY 2017 Product Service ID Dispensed drug identified using NDC 12345678901 Service Provider ID Pharmacy where the prescription was filled 1234567890 Service Provider ID Type of provider identifier 01 Qualifer 1 Prescriber ID Prescriber identification number 1234567890 Prescriber ID Qualifier Type of prescriber identifier 01 1 Starting from YOS 2015, all prescribers are in the NPI format. However, pharmacies still use varieties of format. Hence, it is useful to check the qualifier variable. 10

Opioid NDC List NDC is the drug identifier in Part D claims. Make a list of opioid NDCs by looking into opioid ingredients from publically available drug data such as RxNorm or proprietary databases, such as Medi-Span and First Databank. Morphine Equivalent Conversion factor for each opioid ingredient can be found in the CDC list. Variables of interest: Strength; Unit of measure; Drug ingredients; Dosage form; Route of administration; Drug classification; and the Opioid Morphine Equivalent Conversion Factor. 11

Opioid Claims Using the opioid NDC list, subset the PDE claims data to just opioid claims. Assign variables from opioid NDC list to opioid claims based on the NDCs in the claim dataset. Opioid NDC List Part D Claims Opioid Claims 12

Morphine Equivalent Dosage (MED) Used to convert different opioid products with varying degrees of potency to a comparable dosage ( Morphine Equivalent ) unit. For instance, 10mg of tramadol would be required to have the same potency as 1mg of morphine. Convert all strengths to the unit on the CDC list. For instance, if a NDC has 5mg/0.5ml strength but the conversion factor is based off a unit of 1mg/ml, then the NDC strength needs to be changed to 10mg/ml. MED Daily Dosage = Opioid Strength x Opioid Conversion Factor x (Quantity Supplied / Days Supply) 13

Calculate MED Daily Dosage From Part D Claims: HICN Claim # Quantity Supplied Days Supply Date of Service Number of Dosage Units/Day A 1 20 4 01/01/2016 20/4 = 5 A 2 30 3 01/03/2016 30/3 = 10 From Opioid NDC List: Opioid Strength Opioid Conversion Factor 2 2 3 3 MED Daily Dosage 5x2x2 = 20 10x3x3 = 90 14

Potential Beneficiary Exclusions Beneficiaries with diagnoses or in a setting that legitimizes high opioid usage The Master Beneficiary Summary File (MBSF) Chronic Conditions and Other Chronic or Potentially Disabling Conditions segments can be used to identify beneficiaries with some, but not all, such diagnoses. For the MBSF segment codebooks and record layouts, please visit the CCW website. 15

Potential Overuse Criteria High Duration of Usage High Intensity of Usage Pharmacy and Doctor Shopping Behavior 16

Opioid Analysis Process Step 1 Step 2 Step 3 Make opioid NDC list with opioid conversion factor and strength. Assign conversion factors and strength of opioid NDC to opioid PDE claims. Calculate MED daily dosage for each claim. Step 6 Use opioid overuse criteria to identify opioid over-utilizers. Step 5 Remove potential exclusions. Step 4 Determine each beneficiary s daily opioid usage 17

Medicare Data Request Process: Part D PDE Step 1 State develops data request package with the support of SDRC. Step 2 MMCO or CPI and the Part D Business Owners review the data request and determine whether it meets care coordination and/or program integrity requirements. Step 4 Edaptive and the CMS EFT Team distribute the data to the state. Step 3 CMS Privacy groups review the data request, determine whether the request meets CMS Privacy guidelines, and assign a DUA number. 18

Required Documents: Part D PDE Data Agreements Data Request Package Downstream User Documents Electronic File Transfer (EFT) Information Exchange Agreement (IEA) Cover Letter (New or Additional Data Use) DUA Addendum Form VIES EFT Setup Form Data Use Agreement (DUA) Specification Worksheet DUA Attachment A Form VIES Partner Server Questionnaire Form Conflict of Interest (COI) Letter (No COI or Potential COI) These documents can be found on the SDRC Public website s Request Process Details page. 19

Data Request Package: SDRC Tips Always provide more detail than not enough. When using acronyms, please make sure to spell them out at the first mention. E.g., SDRC should be State Data Resource Center (SDRC). Address the package documents to speak to the specific data type that is being requested. Complete the documents so anyone at CMS, without any prior knowledge, can understand the request fully. 20

Data Request Package: SDRC Tips (Continued) Questions to Keep in Mind: How does the proposed use justifications affect dual eligible beneficiaries at the individual level? How does the lack of data hinder care coordination and/or program integrity initiatives in your state? Do not mention the prohibited HIPAA uses as proposed use justifications for your State Medicaid Agency. Especially related to saving costs. SDRC will review data request package documents, answer any process- or data-related questions, and provide additional guidance to State Medicaid Agencies throughout the entire process. 21

Obtaining Access to the SDRC Assistance website State Medicaid Agency staff can send their full contact information (first and last name, work mailing address, work phone number, and work email address) to sdrc@econometricainc.com. 22

Questions Questions can be submitted through the GoToWebinar question text box. SDRC will read submitted general questions and provide answers If you have questions related to contractual requirements or specific to your state s situation, please email SDRC instead. Some inquiries may require additional research. SDRC will investigate these inquiries and reply via email. 23

Thank You Questions can be submitted to SDRC at: (877) 657-9889 (support line) or sdrc@econometricainc.com. 24